The skin around the eyes is often one of the first areas of the face to show visible signs of ageing. From fine lines and wrinkles to under-eye bags, crepey texture and a loss of firmness, the delicate eye area has its own unique skincare needs.
Launching on 28 August 2026, The Ordinary Lacto-PDRN™ 4% + B9 Eye Cream introduces the brand’s biotechnology-derived vegan alternative to PDRN in a formula designed specifically for the eye area.
The new eye cream combines 4% Lacto-PDRN™, Folic Acid (Vitamin B9) and film-former technology to target visible concerns around the eyes, with benefits designed to provide both immediate visible effects and longer-term improvement.
What Is Lacto-PDRN™?
PDRN, or polydeoxyribonucleotide, has become an increasingly talked-about ingredient in the beauty world.
Traditionally associated with salmon-derived PDRN, the ingredient has gained attention as it moved from professional treatments into the wider skincare market.
The Ordinary takes a different approach with Lacto-PDRN™, which the brand describes as a biotechnology-derived vegan alternative to traditional PDRN.
According to the press release, Lacto-PDRN™ is created through the controlled fermentation of Lactobacillus rhamnosus, a probiotic bacterium. Following fermentation, the bacterial DNA is broken down into short fragments.
The Ordinary selected this microbially derived ingredient based on its targeted data for the delicate eye area while maintaining the brand’s commitment to vegan sourcing.
A Combination of Lacto-PDRN™ and Vitamin B9
At the heart of the formula is 4% Lacto-PDRN™, which The Ordinary says is designed to promote smoother-looking skin and improve the appearance of firmness, wrinkles and elasticity.
The formula also contains Folic Acid, also known as Vitamin B9.
According to The Ordinary, topical Folic Acid helps support skin renewal and elasticity while improving hydration and refining the appearance of skin texture.
Another component of the formula is its film-former technology, which includes Caesalpinia Spinosa Gum and Kappaphycus Alvarezii Extract.
The brand explains that these polysaccharide-based ingredients create a flexible film network on the skin, providing an immediate visible firming and smoothing effect while maintaining a comfortable feel.
Immediate and Longer-Term Visible Benefits
According to clinical testing conducted in The Ordinary’s in-house laboratories, Lacto-PDRN™ 4% + B9 Eye Cream is designed to address a range of visible concerns around the eye area.
The brand reports that the eye cream:
- Visibly lifts the appearance of the eyelids from the first use, with continued improvement over time.
- Immediately tightens the appearance of the eye area to visibly reduce under-eye bags.
- Smooths the appearance of visible texture and crepey eyelids by 17% after eight weeks.
- Minimises the appearance of fine lines under the eyes by 18% after eight weeks.
- Increases skin hydration by 72% within two hours.
- Helps hydrate the delicate eye area while reinforcing the skin barrier.
- Delivers immediate luminosity with lasting radiance.
- Is suitable for use under makeup, including under-eye concealer and foundation.
As with all skincare products, individual results may vary.
Pairing It with The Ordinary GF 15% Solution
For those looking to address visible age-related concerns across the face, The Ordinary also recommends pairing the new eye cream with its GF 15% Solution.
According to the brand, the GF 15% Solution is designed for use across the face for visible skin renewal, while Lacto-PDRN™ 4% + B9 Eye Cream targets the delicate eye area.
Together, the two products are positioned as complementary steps for addressing different visible age-related skin concerns.
Having had the opportunity to try The Ordinary Lacto-PDRN™ 4% + B9 Eye Cream, we found it easy to incorporate into a daily skincare routine. The cream has a lightweight yet nourishing feel and is comfortable to apply around the delicate eye area. We also liked that it can be used under makeup, including concealer and foundation, making it easy to incorporate into both a morning and evening skincare routine.
While longer-term improvements in concerns such as fine lines, texture and firmness naturally require consistent use over time, our initial impression has been positive. The eye cream leaves the eye area feeling hydrated and refreshed, and its combination of Lacto-PDRN™, Vitamin B9 and immediate smoothing technology makes it an interesting addition to The Ordinary’s skincare range. For those curious about the growing interest in PDRN skincare, its biotechnology-derived vegan approach offers another option worth exploring.
The Ordinary Lacto-PDRN™ 4% + B9 Eye Cream will officially launch on 28 August 2026.
Disclaimer: Product and clinical performance claims mentioned in this article are based on information and clinical testing provided by The Ordinary. Individual results may vary.
